These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7566976)

  • 1. Resistance to Fas-mediated apoptosis in human hepatoma cells.
    Natoli G; Ianni A; Costanzo A; De Petrillo G; Ilari I; Chirillo P; Balsano C; Levrero M
    Oncogene; 1995 Sep; 11(6):1157-64. PubMed ID: 7566976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas/APO-1 gene transfer for human malignant glioma.
    Weller M; Malipiero U; Rensing-Ehl A; Barr PJ; Fontana A
    Cancer Res; 1995 Jul; 55(13):2936-44. PubMed ID: 7540953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas-mediated apoptosis in human prostatic carcinoma cell lines.
    Rokhlin OW; Bishop GA; Hostager BS; Waldschmidt TJ; Sidorenko SP; Pavloff N; Kiefer MC; Umansky SR; Glover RA; Cohen MB
    Cancer Res; 1997 May; 57(9):1758-68. PubMed ID: 9135020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways.
    Jiang S; Song MJ; Shin EC; Lee MO; Kim SJ; Park JH
    Hepatology; 1999 Jan; 29(1):101-10. PubMed ID: 9862856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of caspase-8 during N-(4-hydroxyphenyl)retinamide-induced apoptosis in Fas-defective hepatoma cells.
    You KR; Shin MN; Park RK; Lee SO; Kim DG
    Hepatology; 2001 Dec; 34(6):1119-27. PubMed ID: 11732001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis.
    von Reyher U; Sträter J; Kittstein W; Gschwendt M; Krammer PH; Möller P
    Cancer Res; 1998 Feb; 58(3):526-34. PubMed ID: 9458101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis.
    Mori S; Murakami-Mori K; Jewett A; Nakamura S; Bonavida B
    Cancer Res; 1996 Apr; 56(8):1874-9. PubMed ID: 8620507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
    Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
    Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
    Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
    J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cells.
    Shao RG; Cao CX; Nieves-Neira W; Dimanche-Boitrel MT; Solary E; Pommier Y
    Oncogene; 2001 Apr; 20(15):1852-9. PubMed ID: 11313933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S; Meyer E; Debatin KM
    Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
    J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY; Yue P; Hong WK; Lotan R
    Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptotic behaviour of hepatic and extra-hepatic tumor cell lines differs after Fas stimulation.
    Lamboley C; Bringuier AF; Feldmann G
    Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):13-28. PubMed ID: 10726968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of Fas-resistant to Fas-sensitive MCF-7 breast cancer cells by the synergistic interaction of interferon-gamma and all-trans retinoic acid.
    Danforth DN; Zhu Y
    Breast Cancer Res Treat; 2005 Nov; 94(1):81-91. PubMed ID: 16136269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to CD95 (APO-1/Fas)-mediated apoptosis in human renal cell carcinomas: an important factor for evasion from negative growth control.
    Gerharz CD; Ramp U; Déjosez M; Mahotka C; Czarnotta B; Bretschneider U; Lorenz I; Müller M; Krammer PH; Gabbert HE
    Lab Invest; 1999 Dec; 79(12):1521-34. PubMed ID: 10616203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro.
    Papoff G; Cascino I; Eramo A; Starace G; Lynch DH; Ruberti G
    J Immunol; 1996 Jun; 156(12):4622-30. PubMed ID: 8648105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis.
    Cascino I; Papoff G; De Maria R; Testi R; Ruberti G
    J Immunol; 1996 Jan; 156(1):13-7. PubMed ID: 8598453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.